J0223 HCPCS code: Injection, givosiran, 0.5 mg
J0223 is the HCPCS Level II code for injection, givosiran, 0.5 mg. In 2024 Medicare paid an average of $87.00 per service for J0223 across 54,082 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 756 per day on outpatient hospital claims. Medicare volume fell 22% from 2022 to 2024 (69,445 to 54,082 services). In 2024, about 38 clinicians billed Medicare for J0223 for 18 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2020-07-01 |
| Last action effective | 2020-07-01 |
Who bills J0223 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 38 |
| Medicare beneficiaries | 18 |
| States with claims | 0 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J0223, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 69,445 | 19 | $106.00 | $84.55 |
| 2023 | 68,493 | 21 | $108.23 | $86.22 |
| 2024 | 54,082 | 18 | $109.21 | $87.00 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 756 | CMS Policy |
| practitioner claims | 756 | CMS Policy |
What changed for J0223
- 2020-07-01: J0223 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J0223?
J0223 is the HCPCS Level II code for injection, givosiran, 0.5 mg. Short descriptor: "Inj givosiran 0.5 mg".
How much does Medicare pay for J0223?
In 2024, the average Medicare payment was $87.00 per service (average allowed $109.21).
Does Medicare cover J0223?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J0223 can be billed per day?
756 on outpatient hospital claims; 756 on practitioner claims (NCCI medically unlikely edits).
Related J02 codes
- J0200 — Injection, alatrofloxacin mesylate, 100 mg
- J0202 — Injection, alemtuzumab, 1 mg
- J0205 — Injection, alglucerase, per 10 units
- J0206 — Injection, allopurinol sodium, 1 mg
- J0207 — Injection, amifostine, 500 mg
- J0208 — Injection, sodium thiosulfate (pedmark), 100 mg
- J0209 — Injection, sodium thiosulfate (hope), 100 mg
- J0210 — Injection, methyldopate hcl, up to 250 mg
- J0211 — Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)
- J0215 — Injection, alefacept, 0.5 mg
- J0216 — Injection, alfentanil hydrochloride, 500 micrograms
- J0217 — Injection, velmanase alfa-tycv, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J0223
- Watch J0223 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J0223
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.